Pink Sheet Podcast: US FDA Launches Project Orbis And The Rare Disease Cures Accelerator, Looks For Abuse-Deterrent CNS Drugs

Pink Sheet reporters discuss the US FDA's work with other countries to review and approval of cancer therapies at the same time, a new database for rare disease clinical trial and natural history data, and the agency's exploration of abuse-deterrent CNS stimulants.

Senior writers Derrick Gingery and Michael Cipriano discuss the impact of the US Food and Drug Administration's effort to facilitate collaborative review and concurrent approval of cancer treatments in the US and partner countries, the agency's request for comments on development of abuse-deterrent central nervous system stimulants, and the launch of the new Rare Disease Cures Accelerator Data Analytics Platform.

Open Media

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet